Tryp Therapeutics, Inc.GETTEX: 8FW

Elektrotim Adopts Strategy For 2026-2030

· Issued by Tryp Therapeutics, Inc.

Elektrotim SA GPW:ELT:

  • ADOPTS STRATEGY FOR 2026-2030

  • UNDER 2026-2030 STRATEGY COMPANY TO ALLOCATE BETWEEN 50% AND 75% OF ITS NET PROFIT FOR DIVIDEND DISTRIBUTION

  • UNDER 2026-2030 STRATEGY COMPANY TARGETS 1 BILLION PLN REVENUE IN 2030

  • UNDER 2026-2030 STRATEGY COMPANY TARGETS EBITDA UP TO 88 MILLION ZLOTYS IN 2030

  • UNDER 2026-2030 STRATEGY COMPANY TARGETS NET PROFIT AT 67 MILLION ZLOTYS IN 2030

  • UNDER 2026-2030 STRATEGY COMPANY ALSO INCLUDES DIVIDEND POLICY